NEOGENOMICS INC — Director's Dealing 2023

Apr 4, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2023-04-01

Reporting Person: Kulkarni Shashikant (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-04-01	Common Stock	F	3759	—	Disposed	82673	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$12.15	2029-04-01	Common Stock (132744.0)	132744	Direct
Stock Option (Right to Buy)	$10.12	2029-08-01	Common Stock (51653.0)	51653	Direct

Footnotes

F1: Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the April 1, 2023 vesting of restricted stock.

F2: On April 1, 2022, Dr. Kulkarni was granted 132,744 stock options. These options vest ratably over the first four anniversary dates of the grant date.

F3: On August 1, 2022, Dr. Kulkarni was granted 51,653 stock options. These options vest ratably over the first four anniversary dates of the grant date.